GlaxoSmithKline: HIV/AIDS — A Threat to Russia’s National Security

PBN Hill+Knowlton Strategies worked with GlaxoSmithKline, the world’s second largest pharmaceutical company, to ensure that the Russian government applied an effective and fair mechanism to make affordable, state-of-the-art HIV/AIDS medicine available to Russians infected by the disease.
GlaxoSmithKline: HIV/AIDS — A Threat to Russia’s National Security
We worked closely with key ministries in the Russian government as well as leaders of the State Duma, the domestic pharmaceutical industry, the Russian medical profession and patients rights NGOs to increase awareness of the growing HIV/AIDS epidemic in Russia, substantially increase funding for HIV/AIDS and affirm the government’s plans to purchase patented HIV/AIDS drugs from international pharmaceutical companies instead of less expensive generic medicines. As a result, fair pricing for patients and protection of patents for the leading suppliers of these medicines was put into place.